Shorts

Daniel Antonio González Padilla, MD, on the end points of the CREST and POTOMAC trials

Ridwan I. Alam, MD, MPH, on his approach to prostate cancer screening

Kalyani Narra, MD, outlines gaps in referrals for genetic counseling in prostate cancer

Aleece Fosnight, MSPAS, PA-C, on hydration and pelvic floor physical therapy for bladder symptoms

Archan Khandekar, MD, discusses the use of augmented reality with prostate biopsy

Aleece Fosnight, MSPAS, PA-C, on evaluating cyclical bladder symptoms in women

Sevann Helo, MD, shares her advice for urology residency applicants

Pearls & Perspectives: Amy Pearlman, MD, and Nicoletta Heidegger, MA, MEd, LMFT, on sexual medicine myths

Jennifer Miles-Thomas, MD, URPS, MBA, on academic care centers expanding into communities

Ridwan I. Alam, MD, MPH, on the PHI test in men with PSA between 10 and 20 ng/mL

The Expert APProach: Jennifer Bepple, MD, MMCi, on how APPs enhance patient care

Bruno Nahar, MD, on the urologic oncology program at Urology on the Beach

The Expert APProach: What Led Jennifer Bepple, MD, MMCi, to Digital Health

Pearls & Perspectives: Advice for Patients on Disclosing STIs

Aleece Fosnight, MSPAS, PA-C, on hormonally mediated bladder symptoms and IC/BPS

Maxwell Sandberg, MD, outlines trial design for study evaluating treatment of RCC with a tumor thrombus

How an MMAI test can provide reassurance regarding prostate cancer treatment decisions

Jesse Mills, MD, on testosterone therapy and cardiovascular health

Helen L. Bernie, DO, MPH, outlines how she evaluates hypogonadism

Dean Elterman, MD, MSc, FRCSC, describes the efficiencies of the Zenflow system for BPH

How the ProVee System for BPH preserves sexual function

Ilaha Isali, MD, MSc, on X chromosome biology and bladder cancer

Aleece Fosnight, MSPAS, PA-C, on why progesterone affects your bladder during your cycle

Dean Elterman, MD, MSc, FRCSC, on the advantages of the nitinol-based Zenflow system

Steven A. Kaplan, MD, on the ProVee System’s potential to replace medication for BPH

Raveen Syan, MD, FPMRS, on the Rising Star program at Urology on the Beach

Mark L. Gonzalgo, MD, PhD, MBA, outlines what to expect from Urology on the Beach 2026

Steven Monda, MD, on germline variants in urothelial cancer

Mohit Khera, MD, MBA, MPH, on why TRT should not be a Schedule III controlled substance

Jesse Mills, MD, on the effects of pairing anastrozole with TRT